| Literature DB >> 30093951 |
Xiaomei Chen1,2, Peilong Lai2, Yulian Wang2, Chang He3, Suijing Wu2, Xin Huang2, Suxia Geng2, Chengwei Luo2, Wei Ling2, Lingji Zeng2, Peng Li4, Zhiwu Jiang4, Jianyu Weng2, Xin Du1,2.
Abstract
Chronic graft-versus-host disease (cGVHD) manifests with features characteristic of autoimmune disease with organs attacked by pathogenic Th17 cells. However, the mechanism of Th17 cells generation in the setting of cGVHD is still unclear. Here we defined C5a/C5aR-IL-17Aaxis as a novel signaling that required in the pathologies of cGVHD. We firstly found a positive link between complement activation and the Th17 cells in patients with cGVHD. C5a, a critical component of complements, promoted the generation of Th17 cells in vitro and inhibition of the receptor for C5a (C5aR) reduced the Th17-bias response. Of note, C5aR blockade by PMX53 could suppress the generation of IL-17A-expressing Th17 cells and retard the onset and progression of cGVHD in vivo. Overall, our results provide new mechanistic insights that activation of C5a-C5aR signaling was required for IL-17A-induced immune responses in cGVHD and define novel molecular targets for developing effective therapeutics for cGVHD.Entities:
Keywords: Chronic graft-versus-host disease (cGVHD); Complement C5a; Interleukin-17A (IL-17A); Th17 cells
Year: 2018 PMID: 30093951 PMCID: PMC6079133
Source DB: PubMed Journal: Am J Transl Res Impact factor: 4.060